Tax Credit For Rare Disease Or Conditions
The Orphan Drug Tax Credit applies to qualified clinical trial expenses designated for rare disease or conditions. These conditions are usually called “orphan drugs”.
A Nonrefundable Orphan Drug Tax Credit Of 50% Of Qualifying Expenses
The orphan drug tax credit covers 50% of the clinical testing expenses, reducing the costs of developing drugs and products for small patient population.
Tax News Updates:
Amicus Therapeutics Announces First Quarter 2012 Financial Results
... at the forefront of developing therapies for rare and orphan diseases, ... for the US Food and Drug Administration (FDA) and other regulatory agencies.
EUSA Swings Ideal Exit with $700M Acquisition by Jazz
In addition Jazz has agreed on a $100 million revolving credit facility. ... Despite its long history, Erwinaze has orphan drug exclusivity until 2018 and ...
FDA Expands Everolimus Label
Companies that produce orphan drugs receive a tax credit and are exempted from paying the prescription drug user fee normally required for new drug ...
Medgenics Files for U.S. Orphan Drug Designation for INFRADURE for ...
Obtaining Orphan Drug Designation could be the most rapid route for us to bring ... including the availability of grant money, certain tax credits and seven ...